1. Home
  2. CRMT vs OMER Comparison

CRMT vs OMER Comparison

Compare CRMT & OMER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRMT
  • OMER
  • Stock Information
  • Founded
  • CRMT 1981
  • OMER 1994
  • Country
  • CRMT United States
  • OMER United States
  • Employees
  • CRMT N/A
  • OMER N/A
  • Industry
  • CRMT Other Specialty Stores
  • OMER Biotechnology: Pharmaceutical Preparations
  • Sector
  • CRMT Consumer Discretionary
  • OMER Health Care
  • Exchange
  • CRMT Nasdaq
  • OMER Nasdaq
  • Market Cap
  • CRMT 266.5M
  • OMER 274.3M
  • IPO Year
  • CRMT N/A
  • OMER 2009
  • Fundamental
  • Price
  • CRMT $25.77
  • OMER $7.62
  • Analyst Decision
  • CRMT Buy
  • OMER Strong Buy
  • Analyst Count
  • CRMT 1
  • OMER 6
  • Target Price
  • CRMT $45.00
  • OMER $27.50
  • AVG Volume (30 Days)
  • CRMT 154.1K
  • OMER 8.2M
  • Earning Date
  • CRMT 12-04-2025
  • OMER 11-12-2025
  • Dividend Yield
  • CRMT N/A
  • OMER N/A
  • EPS Growth
  • CRMT N/A
  • OMER N/A
  • EPS
  • CRMT 1.61
  • OMER N/A
  • Revenue
  • CRMT $1,378,681,000.00
  • OMER N/A
  • Revenue This Year
  • CRMT $3.49
  • OMER N/A
  • Revenue Next Year
  • CRMT $5.72
  • OMER N/A
  • P/E Ratio
  • CRMT $15.86
  • OMER N/A
  • Revenue Growth
  • CRMT 0.64
  • OMER N/A
  • 52 Week Low
  • CRMT $24.85
  • OMER $2.95
  • 52 Week High
  • CRMT $62.72
  • OMER $13.60
  • Technical
  • Relative Strength Index (RSI)
  • CRMT 36.10
  • OMER 62.54
  • Support Level
  • CRMT $24.85
  • OMER $7.43
  • Resistance Level
  • CRMT $28.45
  • OMER $12.10
  • Average True Range (ATR)
  • CRMT 1.42
  • OMER 0.69
  • MACD
  • CRMT 0.47
  • OMER 0.25
  • Stochastic Oscillator
  • CRMT 18.17
  • OMER 44.74

About CRMT America's Car-Mart Inc

America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and, in the majority of cases, a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.

About OMER Omeros Corporation

Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders. The drug candidate in the pipeline of complement-targeted therapeutics is narsoplimab (OMS721), a proprietary, patented human monoclonal antibody targeting mannan-binding lectin-associated serine protease 2, the key activator of the lectin pathway of complement. Clinical development of narsoplimab is currently focused on hematopoietic stem cell transplant-associated thrombotic microangiopathy and immunoglobulin nephropathy.

Share on Social Networks: